SPEAKER_00

The FDA with the regulators, they knew what they were doing, the design of the process, everything was being talked about.

Right.

And they get a let's wait.

You know, I mean, just from the ones I hold in my heart.

Look, I think that's a component, right?

We were talking about public perception and that changing and then that pressuring and things changing as well.

I think this is a paradigm changing and shifting thing that the entire system, including pharma and all these people that are on these boards, these decision makers, power brokers, right, are trying to make sense of.

And I'll explain.

We have an identified disorder or challenge.

We have a medicine that masks that symptom.

This is going to allow people to truly heal.

When you truly heal, you don't have to keep taking a medicine.

You might have to come back to it periodically.

Sure.

Let's call that a flare up.

Yeah.

Let's call it a touch up.

But when you're not taking your pill every day, every other day, that's going to be a big hit.

Yeah.

To people's power and money.